Mechanism and Clinical Efficacy of Peripheral Blood Alive Cell Treatment on Androgenic Alopecia

    July 2024 in “ Chinese Medical Journal
    Zigang Zhao, Xin Zhang, Xiaoyan Qu, Yaguang Zhou, Shui Yu, Q. Wang, Qian Zhang
    Image of study
    TLDR Peripheral blood alive cell treatment is effective and safe for treating hair loss.
    The study investigated the efficacy and safety of peripheral blood alive cell treatment (ACT) for androgenic alopecia (AGA) in 60 male volunteers, divided into ACT and ACT + finasteride (FNS) groups. Both groups showed significant increases in hair counts after 6 months, with the ACT + FNS group showing improvements at both 3 and 6 months. The efficacy rates were 75.0% for ACT and 81.3% for ACT + FNS, with no significant difference between the groups. ACT was found to promote hair follicle cell proliferation, migration, and blood circulation, reduce cell apoptosis, and activate Wnt/β-catenin signaling. The treatments were effective and safe, showing promising clinical potential for AGA.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 38 results

    Related Research

    1 / 1 results